Qnexa Articles
US FDA approves second diet pill, Vivus' Qsymia
18 July 2012
Vivus says FDA has delayed Qnexa PDUFA date
10 April 2012
FDA advisory panel backs approval of Qnexa
23 February 2012
FDA updates on obesity drug candidates
11 January 2012
Obesity drug market set to grow to $2.6 billion by 2020, says DR report
27 September 2011
Vivus agrees pathway with US FDA for re-submission of Qnexa NDA
16 September 2011
ADA meeting hears news of XOMA’s new classes of insulin receptor-regulating Ab and Vivus’ Qnexa
27 June 2011
Topiramate carries risk of birth defect, says US FDA
7 March 2011
US FDA approves additional medical indication for Bristol-Myers Squibb’s Sprycel; clears Sunovion’s Latuda; further delays Vivus’ Qnexa
29 October 2010
Showing 1-20 of 20 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
